fda banning semaglutide Hims & Hers stock falls 25% as curtails compounded GLP-1s FDA approves obesity drug that

Barhwal K, Hota SK, Prasad D, Singh SB, Ilavazhagan G

[00:08:23.390] Well, David, weve had conversations at Lid with with retail, North American-based retailers, global in scale, some of them, who, when theyre thinking about their Canadian supply chain, are asking themselves, well, if Im going to renew my Canadian infrastructure and put a large facility and put a large amount of capital into the greater Toronto area, and Im going to have a Canadian e-commerce operation anyway, why not greatly expand grant that operation and run my entire North American e-commerce operation there because the de minimis loophole allows me to

While the science is still catching up, Byrne suspects that middle-aged women may be particularly vulnerable to "Ozempic face" because of hormonal shifts and a natural decline in collagen production during the menopause transition

If no weight loss is seen after 6 weeks, it could be due to several factors like non-adherence to diet/lifestyle changes, underlying health issues, or the individual may not respond well to semaglutide treatment

And one in five have taken the medication in the past

Compounded GLP-1 supply and behavioral support are included when these services are part of clinical care